Cohance Lifesciences shareholders and shareholding pattern
NSE: COHANCEBSE: 543064Pharmaceuticals & BiotechnologySmall Cap
Formerly Suven Pharmaceuticals
Last close ₹449.85down ₹4.00 (0.88%)BSE ₹448.65
Share price at the NSE close on 23 Oct 2026. Previous close ₹453.85.
52-week range of traded prices to 23 Oct 2026
₹266.70Low, 9 Mar 2026₹903.40High, 23 Oct 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹17,211 Cr428th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 5 Aug 2026
- 162.0
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹21 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 134.9
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 12 May 2026
- 4.4
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 5 Aug 2026
- 3.8%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹21 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 4.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 5 Aug 2026
- 3.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 12 May 2026
- 0.04
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 5,73,70251.1% delivered
Who owns Cohance Lifesciences, filing by filing
Per cent of all the company's shares, counting those held against depositary receipts traded abroad where a filing has them. Every filing on record, from Jun 2020; the latest is the filing for Sep 2026.
Sep 2026 filing
- Promoters57.48%
- Foreign institutions7.71%
- Indian institutions18.86%
- GovernmentsNone
- Individuals and others15.95%
- Depositary receiptsNone
Shareholding pattern, per cent, from Sep 2022
- Promoters
- Foreign institutions
- Indian institutions
- Governments
- Individuals and others
- Depositary receipts
| Per cent | Jun 2020Filed 18 Jul | Sep 2020Filed 13 Oct | Dec 2020Filed 18 Jan | Mar 2021Filed 9 Apr | Jun 2021Filed 19 Jul | Sep 2021Filed 12 Oct | Dec 2021Filed 10 Jan | Mar 2022Filed 13 Apr | Jun 2022Filed 15 Jul | Sep 2022Filed 20 Oct | Dec 2022Filed 11 Jan | Mar 2023Filed 13 Apr | Jun 2023Filed 11 Jul | Sep 2023Filed 21 Oct | Dec 2023Filed 19 Jan | Mar 2024Filed 17 Apr | Jun 2024Filed 19 Jul | Sep 2024Filed 17 Oct | Dec 2024Filed 20 Jan | Mar 2025Filed 17 Apr | Jun 2025Filed 21 Jul | Sep 2025Filed 16 Oct | Dec 2025Filed 21 Jan | Mar 2026Filed 21 Apr | Jun 2026Filed 17 Jul | Sep 2026Filed 15 Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 60.00% | 60.00% | 60.00% | 60.00% | 60.00% | 60.00% | 60.00% | 60.00% | 60.00% | 60.00% | 60.00% | 60.00% | 60.00% | 60.00% | 60.00% | 50.10% | 50.10% | 50.10% | 50.10% | 50.10% | 66.41% | 57.49% | 57.49% | 57.49% | 57.49% | 57.48% | |
| Indian promoters | 60.00% | 60.00% | 60.00% | 60.00% | 60.00% | 60.00% | 60.00% | 60.00% | 60.00% | 60.00% | 60.00% | 60.00% | 60.00% | 9.90% | 9.90% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | – | – | – | – | – | – |
| Foreign promoters | – | – | – | – | – | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 50.10% | 50.10% | 50.10% | 50.10% | 50.10% | 50.10% | 50.10% | 66.41% | 57.49% | 57.49% | 57.49% | 57.49% | 57.48% |
| Public. Every shareholder outside the promoter group, the employee trusts and the shares held against depositary receipts, as the filing totals them. | 40.00% | 40.00% | 40.00% | 40.00% | 40.00% | 40.00% | 40.00% | 40.00% | 40.00% | 40.00% | 40.00% | 39.99% | 40.00% | 40.00% | 40.00% | 49.90% | 49.90% | 49.90% | 49.90% | 49.90% | 33.59% | 42.51% | 42.51% | 42.51% | 42.51% | 42.52% |
| Depositary receipts | – | – | – | – | – | – | – | – | – | – | – | 0.01% | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Promoter shares pledgedShare of the promoters' own shares | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 94.56% | 94.56% |
| Shares in issue | 12,72,82,478 | 12,72,82,478 | 25,45,64,956what Shares in issue, Dec 2020, includes. Bonus issue on 25 Sep 2020: 1 new share for every 1 held. Earlier filings count the shares before it. | 25,45,64,956 | 25,45,64,956 | 25,45,64,956 | 25,45,64,956 | 25,45,64,956 | 25,45,64,956 | 25,45,64,956 | 25,45,64,956 | 25,45,64,956 | 25,45,64,956 | 25,45,64,956 | 25,45,64,956 | 25,45,64,956 | 25,45,64,956 | 25,45,64,956 | 25,45,64,956 | 25,45,64,956 | 38,25,67,140 | 38,25,67,140 | 38,25,67,140 | 38,25,67,140 | 38,25,67,140 | 38,25,97,330 |
| Shares locked inShares locked in. Shares the filing reports as barred from sale until a set day, such as promoters' shares after a public issue or shares allotted to an investor directly. | – | – | – | – | 2,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | – | – | – | – | – | – |
| Shares underlying depositary receipts | – | – | – | – | – | 0 | 0 | 0 | 0 | 0 | 0 | 26,645 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | – | – | – | – | – | – |
Filings before Sep 2022 are on an older form, which did not split institutions into foreign and Indian and grouped some holders differently, so those columns show only the lines both forms state alike. Pledged is the share of the promoters' own shares given to lenders as security. A dash is a line the filing did not state. “Under 0.01%” is a holding of shares too small to show at two decimals.
Cohance Lifesciences promoters
Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is BEHRYANDA LIMITED, 33.34%.Promoter buying and selling
| Holder | |||
|---|---|---|---|
| BEHRYANDA LIMITEDForeign companies and others | 33.34% | 12,75,39,592 | 100.00% |
| JUSMIRAL HOLDINGS LIMITEDForeign companies and others | 24.15% | 9,23,90,578 | 87.06% |
Pledged is the share of the holder's own shares pledged to a lender.
Largest public holders of Cohance Lifesciences, filing by filing
Per cent, on the same shares as the split above.Mutual funds holding Cohance Lifesciences
| Holder | Jun 2020Filed 18 Jul | Sep 2020Filed 13 Oct | Dec 2020Filed 18 Jan | Mar 2021Filed 9 Apr | Jun 2021Filed 19 Jul | Sep 2021Filed 12 Oct | Dec 2021Filed 10 Jan | Mar 2022Filed 13 Apr | Jun 2022Filed 15 Jul | Sep 2022Filed 20 Oct | Dec 2022Filed 11 Jan | Mar 2023Filed 13 Apr | Jun 2023Filed 11 Jul | Sep 2023Filed 21 Oct | Dec 2023Filed 19 Jan | Mar 2024Filed 17 Apr | Jun 2024Filed 19 Jul | Sep 2024Filed 17 Oct | Dec 2024Filed 20 Jan | Mar 2025Filed 17 Apr | Jun 2025Filed 21 Jul | Sep 2025Filed 16 Oct | Dec 2025Filed 21 Jan | Mar 2026Filed 21 Apr | Jun 2026Filed 17 Jul | Sep 2026Filed 15 Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| JASUB PROPERTY HOLDINGS LLPCompanies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 3.84% | 3.84% | 3.84% |
| JASTI PROPERTY AND EQUITY HOLDINGS PRIVATE LIMITEDCompanies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 9.90% | 9.90% | 9.90% | 9.90% | 6.59% | 6.57% | 6.41% | 2.51% | 2.51% | 2.51% |
| AMANSA HOLDINGS PRIVATE LIMITEDForeign portfolio investors, category I | – | – | – | – | – | – | – | – | – | – | – | 2.56% | 2.56% | 2.38% | 2.38% | – | – | – | – | – | – | – | – | – | – | 2.18% |
| SBI LIFE INSURANCE CO. LTDInsurance companies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.10% | 1.91% | 2.85% | 2.99% | 2.10% | 2.78% | 2.77% | 2.02% | 1.75% | 1.75% |
| TATA AIA LIFE INSURANCE COMPANY LIMITED A/C GROUPInsurance companies | – | – | – | – | – | – | – | – | 1.86% | – | – | 2.15% | – | – | – | – | – | – | – | – | – | 1.00% | – | – | – | – |
| GOLDMAN SACHS FUNDS - GOLDMAN SACHS INDIA EQUITY PForeign portfolio investors, category I | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.11% | 1.16% | 1.19% | 1.09% | 1.23% | – | – | – | – | – | – |
| JASTI PROPERTY AND EQUITY HOLDINGS PRIVATE LIMITED (initscapacityassoletrusteeofJastiFamilyTrust)Companies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 9.90% | – | – | – | – | – | – | – | – | – | – |
| RAMBABU CHIRUMAMILLANon-resident Indians | 2.24% | 2.31% | 2.31% | 2.23% | 2.14% | 2.03% | 2.25% | 2.20% | 2.22% | 2.26% | 2.23% | 2.23% | 2.23% | – | – | – | – | – | – | – | – | – | – | – | – | – |
| ALPHA ALTERNATIVES MSAR LLPAlternative investment funds | – | – | – | – | – | – | – | – | – | – | – | – | 1.09% | – | – | – | – | – | – | – | – | – | – | – | – | – |
| TATA AIA LIFE INSURANCE CO LTD-TOP 50 FUND-ULIF 02Insurance companies | – | – | – | – | – | – | – | – | – | – | 2.15% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| TATA AIA LIFE INSURANCE CO LTD-LARGE CAP EQUITY FUNDInsurance companies | – | – | – | – | – | – | – | – | – | 2.15% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| TATA AIA LIFE INSURANCE COMPANY LTD - NON UNIT LINOther non-institutions | – | – | – | – | – | – | 1.46% | 1.86% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| UTI INDIA DYNAMIC EQUITY FUNDInstitutions Foreign Portfolio Investor | – | – | – | – | – | – | 1.03% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| TAIYO GREATER INDIA FUND LTDInstitutions Foreign Portfolio Investor | 1.30% | – | 1.03% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. Mutual funds are left out here: each fund's holding is on the Mutual funds tab, from its own portfolio. A dash is a filing that did not name the holder, which includes holding under one per cent.